Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study

Concerns over unacceptable high mortality in patients with rectal cancer undergoing surgery or systemic therapy who contract COVID-19 have led to widespread adoption of alternative treatment strategies.The ReCaP study aimed to study these variations and associated outcomes.

Automated summary

The high mortality rate in rectal cancer patients with COVID-19 has prompted the adoption of alternative treatment strategies. The ReCaP study aims to study these variations and associated outcomes.